S9 - Aging and Dementia: Clinical Trials and Novel Therapies
| Event Time: | Sunday May 5, 2019 3:30 pm to 5:30 pm |
| Topic(s): | Aging, Dementia, Cognitive, and Behavioral Neurology |
| Director(s): | |
| Description: | |
| Completion Message: | |
| CME Credits: | 2 |
| Core Competencies: |
| Start/End Time | Title | Faculty |
|---|---|---|
| 5:10 PM - 5:30 PM | Q&A Panel with Authors | Faculty |
| Speaker | Disclosure |
|---|
| Start Time | Pub. | Title | Presenter |
|---|---|---|---|
| 3:30 PM | 001 | Bi-directional Analysis of Tau Propagation between Braak Stages along Functional Connectivity Pathways |
Disclosure: Dr. Seemiller has nothing to disclose.
|
| 3:30 PM | 002 | Different Rates of Lobar Atrophy Between Symptomatic and Asymptomatic MAPT Mutation Carriers |
Disclosure: Dr. Boeve has received research support from GE Heathcare and Axovant.
|
| 3:30 PM | 003 | The Brain Health Champion Study: Promoting Non-Pharmacological Interventions in Cognitive Disorders |
Disclosure: Dr. Gale has nothing to disclose.
|
| 3:30 PM | 004 | Development of antisense oligonucleotides for prion disease |
Disclosure: Dr. Vallabh has nothing to disclose.
|
| 3:30 PM | 005 | AAV-Mediated Progranulin Delivery to a Mouse Model of FTD/CNL Causes T Cell-Mediated Toxicity |
Disclosure: Dr. Amado has nothing to disclose.
|
| 3:30 PM | 007 | Consistently large amyloid reductions in patients with and without ARIA-E in the gantenerumab SCarlet RoAD and Marguerite RoAD open-label extension studies |
Disclosure: Dr. Klein has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche.
|
| 3:30 PM | 008 | The Effects of Memantine Added to Cholinesterase Inhibitors on NPI Behavioral Domains: Pooled Post Hoc Analysis of 3 Randomized Controlled Trials in Patients With Moderate to Severe AD |
Disclosure: Dr. Cummings has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Acadia, Accera, Actinogen, AgeneBio, Alkahest, Allergan, Alzheon, Avanir, Axsome, Binomics, BiOasis Technologies, Biogen, Bracket, Denali, Diadem, EIP Pharma, Eisai, Genentech, Green Valley, Grifols, Hisun, Idorsia, Lundbeck, MedAvante, Merck, Otsuka, Pain Therapeutics, Probiodrug, Proclara, QR, Resverlogix, Roche, Samumed, Shinkei Therapeutics, Sunovion, Suven, Takeda and United Neuroscience pharmaceutical and assessment companies. Dr. Cummings has received royalty, license fees, or contractual rights payments from Neuropsychiatric Inventory. Dr. Cummings has received research support from Avid and Teva.
|
| 3:30 PM | 009 | Identifying Factors that Predict Complications and Influence Participation in Longitudinal Cerebrospinal Fluid Biomarker Studies |
Disclosure: Dr. Day has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with DynaMed (EBSCO Health). Dr. Day holds stock and/or stock options in ANI Pharmaceuticals (a generic pharmaceutical company).
|
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C1 -
What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders
Daniel Kaufer MD, FAAN |
| 9:30 AM-11:30 AM |
|
C13 -
Clinicopathological Correlation Session in Dementia
David Irwin MD |
| 1:30 PM-3:30 PM |
|
C32 -
The Neurology of Social Behavior
Bradford Dickerson MD, FAAN |
| 4:15 PM-5:30 PM |
|
Hot Topics Plenary Session
Eric Klawiter MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C37 -
Chronic Traumatic Encephalopathy: Update
Andrew Budson MD |
| 11:30 AM-6:30 PM |
|
P1 -
Poster Session 1
|
| 1:00 PM-3:00 PM |
|
C60 -
Assessment of Rapidly Progressive Dementias I: Prion and Non-prion Neurodegenerative Diseases
Michael Geschwind MD, PhD, FAAN |
| 3:30 PM-5:30 PM |
|
C76 -
Assessment of Rapidly Progressive Dementias II: Infections and Autoimmune Mediated Conditions
Michael Geschwind MD, PhD, FAAN |
|
C67 -
Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
| 7:00 AM-9:00 AM |
|---|
|
C78 -
Young Onset and Atypical Alzheimer's Dementia
Jonathan Graff-Radford MD |
|
C85 -
Severe TBI: From ICU to Rehabilitation
Susanne Muehlschlegel MD, MPH |
| 8:00 AM-8:45 AM |
|
Physical Exercise and Cognitive Training in Neurology-Application in Aging & Neurodegenerative Disease
Ergun Uc MD |
| 9:15 AM-12:00 PM |
|
Contemporary Clinical Issues Plenary Session
Randolph Marshall MD, FAAN |
| 11:30 AM-6:30 PM |
|
P2 -
Poster Session 2
|
| 1:00 PM-3:00 PM |
|
C88 -
Mild Cognitive Impairment: Implications for Clinicians
Ronald Petersen PhD, MD, FAAN |
|
S13 -
Behavioral and Cognitive Neurology: Behavioral Neurology, Aging, and Dementia
|
| 3:30 PM-5:30 PM |
|
C106 -
Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment
David Knopman MD, FAAN |
|
Presentation of the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
|
| 5:00 PM-5:45 PM |
|
Defining, Evaluating, and Promoting Healthy Cognitive Aging
Kirk Daffner MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C122 -
Neurocognitive Assessment for Neurologists
Mario Mendez MD, PhD, FAAN |
| 9:15 AM-11:30 AM |
|
Clinical Trials Plenary Session
Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN |
| 11:30 AM-6:30 PM |
|
P3 -
Poster Session 3
|
| 1:00 PM-3:00 PM |
|
C132 -
Frontotemporal Dementias
Elizabeth Finger MD, FAAN |
| 3:30 PM-5:30 PM |
|
C151 -
Lewy Body Dementias
Karen Marder MD, MPH, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C166 -
Neuroimaging Biomarkers Across the Dementia Spectrum
Liana Apostolova MD, FAAN |
| 11:30 AM-6:30 PM |
|
P4 -
Poster Session 4
|
| 1:00 PM-3:00 PM |
|
C176 -
Behavioral Neurology I: Network Anatomy of Behavior and Language
Maria Gorno Tempini MD, PhD |
|
S34 -
Aging and Dementia: Risk Factors, Biomarkers, and Neuropathology
|
| 3:30 PM-5:30 PM |
|
C193 -
Behavioral Neurology II: Memory and Attention
Maria Gorno Tempini MD, PhD |
| 5:00 PM-5:45 PM |
|
Case Studies: When to Refer Patients for Cognitive Behavioral or Mindfulness-based Psychotherapies: Expanding the Neurologist's Toolkit
David Perez MD, Aneeta Saxena MD, Gaston Baslet MD |
| 7:00 AM-9:00 AM |
|---|
|
C206 -
Vascular Cognitive Impairment and Dementia: Current Status and Future
Larry Goldstein MD, FAAN, FAHA |
| 11:30 AM-6:30 PM |
|
P5 -
Poster Session 5
|
| 11:45 AM-12:30 PM |
|
How Your Social Life Might Be Helping (or Harming) Your Brain
Joel Salinas MD |
| 1:00 PM-3:00 PM |
|
C216 -
Higher Cortical Visual Disorders: Case-based Review
Sashank Prasad MD |
| 3:30 PM-5:30 PM |
|
IS3 -
Invited Science: Aging and Dementia
Karen Marder MD, MPH, FAAN, Heather Snyder PhD |
| 5:00 PM-5:45 PM |
|
Influence of a Comprehensive Lifestyle Intervention on Prevention of Dementia
Ayesha Sherzai MD, Dean Sherzai MD, MAS, PhD |
| 7:00 PM-10:00 PM |
|
C242 -
Case Studies: Dementia
Gregory Day MD, MSc |
| 9:15 AM-11:30 AM |
|---|
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 11:45 AM-12:45 PM |
|
Friday Grand Finale: Neuroimaging
|
| 1:00 PM-3:00 PM |
|
C252 -
Update in Aging and Dementia
Gil Rabinovici MD |
| 3:30 PM-4:30 PM |
|
C255 -
Education Blitz: Normal Pressure Hydrocephalus
Neill Graff-Radford MD, FAAN |